Manipal Hospitals
| Índia | Turki | Austria | |
| Pengobatan hipertensi pulmonal dengan sel punca | dari $8,500 | dari $12,000 | dari $55,000 |
| Aferesis LDL | dari $1,400 | dari $1,650 | - |
Bookimed tidak menambah biaya tambahan dalam harga perawatan Hipertensi pulmonal. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Hipertensi pulmonal dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Hipertensi pulmonal Anda.
For pulmonary hypertension in India, you should consult a specialized pulmonologist or cardiologist. Ideally, choose a specialist focused on pulmonary vascular diseases at a JCI-accredited tertiary center. These experts manage the complex interaction between your heart and lungs through advanced diagnostic testing.
Bookimed Expert Insight: While India has over 90 specialized clinics, Global Hospital Chennai stands out for advanced cases. It is credited with the first successful lung and combined heart-kidney transplant in the country. This level of surgical expertise is rare. It indicates a facility capable of handling the most severe pulmonary vascular complications.
Patient Consensus: Patients emphasize starting with a pulmonologist for the initial workup. They note that choosing a large multispecialty hospital ensures all necessary imaging and specialists are in one location.
Right heart catheterization is the definitive test used by Indian hospitals to confirm pulmonary hypertension. This invasive procedure directly measures blood pressure inside the pulmonary arteries. Indian clinicians consider it the gold standard. It is required to establish a formal diagnosis before starting intensive therapy.
Bookimed Expert Insight: While India hosts 92 clinics for this condition, large centers like Global Hospital Chennai and Manipal Hospitals offer superior diagnostic depth. These facilities maintain specialized pulmonology departments alongside high-volume cardiology wings. This is vital because RHC results must be paired with lung function tests and high-resolution imaging to identify the underlying cause. Choosing a center with both National Accreditation Board for Hospitals and Healthcare Providers (NABH) and advanced pulmonary labs ensures your definitive test results are accurate.
Patient Consensus: Patients emphasize that an echocardiogram is just the first step. They note that a diagnosis is not actually final until the right heart catheterization is performed.
India provides various targeted medications for pulmonary arterial hypertension including PDE-5 inhibitors and endothelin receptor antagonists. Local pharmaceutical manufacturing ensures advanced therapies like sildenafil and ambrisentan are accessible. Most treatments are available through tertiary cardiology and pulmonology centers like Global Hospital Chennai and Manipal Hospitals.
Bookimed Expert Insight: Patients should prioritize tertiary facilities like Global Hospital Chennai which ranks among the worlds best. These high-volume centers handle over 80,000 patients annually and perform specialized lung transplants. Their internal pharmacies stabilize access to newer therapies like macitentan which are harder to find in outpatient clinics.
Patient Consensus: Patients note that sildenafil is the most accessible option due to widespread generic availability. Many emphasize that advanced combination therapies are best managed through specialist hospital pharmacies to ensure consistent stock.
Advanced prostacyclin analogues like Epoprostenol and Treprostinil are not locally manufactured or marketed in India. Patients with severe pulmonary hypertension can legally import these drugs for personal use through CDSCO Form 12A. Locally available oral options like Selexipag provide strong receptor-targeted therapy for advanced cases.
Bookimed Expert Insight: While parenteral prostacyclins are not sold in local pharmacies, India represents a global hub for pulmonary innovation. Global Hospital Chennai performed the first minimally invasive lung transplant in India. This suggests that for end-stage cases where medication limits are reached, Indian centers offer surgical alternatives that may be more sustainable than long-term drug imports.
Patient Consensus: Patients note that while advanced drugs exist in principle, the logistics of continuous infusion and catheter care are best managed at major metropolitan hospitals. Many emphasize that getting a specialized evaluation at a high-volume center is the first step toward accessing these restricted therapies.
Top Indian hospitals provide advanced interventions like balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic disease. Tertiary centers also offer bilateral lung transplantation for end-stage cases. JCI-accredited facilities utilize specialized catheterization labs to perform life-saving shunts and atrial septostomy for right-side heart decompression.
Bookimed Expert Insight: Data from leading facilities like Global Hospital Chennai shows a high concentration of expertise in complex thoracic procedures. This center achieved a national milestone by performing the first minimally invasive lung transplant in India. Patients seeking advanced surgical relief should prioritize clinics with multidisciplinary pulmonary hypertension teams. These high-volume centers, which serve up to 80,000 patients annually, often provide the necessary specialized imaging required for transplant and surgery eligibility.
Patient Consensus: Patients emphasize the need for early referral to high-volume centers to reduce surgical risks. Many note that choosing between surgery or balloon interventions depends heavily on where clots are located in the anatomy.
Top centers for pulmonary hypertension in India include JCI-accredited facilities like BLK Super Speciality Hospital and NABH-certified Medanta Hospital. These institutions feature multidisciplinary teams combining cardiology and pulmonology. They utilize advanced diagnostics like right heart catheterization and specialized pulmonary imaging to manage complex vascular diseases.
Bookimed Expert Insight: Patient data suggests looking beyond general cardiology departments to clinics with specific pulmonary vascular experience. Global Hospital Chennai stands out because it treats 80,000 patients annually and pioneered minimally invasive lung transplants in India. This high volume often correlates with better outcomes for rare, complex conditions like pulmonary hypertension.
Patient Consensus: Patients note it is vital to choose large tertiary centers that can coordinate cardiology and pulmonology care under one roof. They recommend bringing all previous echo and CT reports to your first visit to speed up the treatment process.
Pulmonary hypertension is generally a chronic condition without a universal cure. However, specialized Indian centers can fully reverse specific types. Success depends on treating underlying causes like heart defects or chronic blood clots using surgery. Advanced therapies in India focus on symptom control and lifespan extension.
Bookimed Expert Insight: While most clinics focus on management, Global Hospital Chennai stands out for complex cases. It performed Indias first minimally invasive lung and combined heart-kidney transplants. For patients with treatment-resistant hypertension, this advanced surgical capability is a critical safety net. High-volume centers like Manipal Hospitals serve 2,000,000 patients annually, ensuring deep experience in diagnostic accuracy.
Patient Consensus: Patients note that while a full cure is rare, symptoms improve significantly with early care. Many emphasize the need to find specialists who identify the exact cause before starting treatment.